Home » Topics » BioWorld Science

BioWorld Science
RSS

BioCryst Pharmaceuticals patent details complement factor D inhibitors

May 6, 2021

Pipeline Therapeutics synthesizes muscarinic M1 receptor antagonists

May 6, 2021

Combination of pacritinib/sirolimus/low-dose tacrolimus for GvHD: preclinical and phase I results

May 6, 2021

Boswellic acid derivative inhibits Th17 cell differentiation by targeting eIF2alpha

May 6, 2021

Silverback Therapeutics patents TGFBR1 inhibitors

May 6, 2021

Study identifies four Alzheimer's subtypes

May 6, 2021

Novel GLUT5 inhibitor molecule to treat fructose-induced diseases

May 6, 2021

Oral oncolytic reovirus RC-402 elicits potent immune responses against colon cancer

May 6, 2021

Seqirus quadrivalent influenza vaccine Flucelvax noninferior to standard in children

May 6, 2021

Vivace advances phase I trial of VT-3989 in solid tumors

May 6, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...